HC Wainwright restated their buy rating on shares of Ocuphire Pharma (NASDAQ:OCUP – Free Report) in a research note released on Monday morning, Benzinga reports. The brokerage currently has a $20.00 target price on the stock. HC Wainwright also issued estimates for Ocuphire Pharma’s Q2 2024 earnings at ($0.29) EPS, Q3 2024 earnings at ($0.29) […]
HC Wainwright reissued their buy rating on shares of Ocuphire Pharma (NASDAQ:OCUP – Free Report) in a research report released on Monday morning, Benzinga reports. The firm currently has a $20.00 target price on the stock. HC Wainwright also issued estimates for Ocuphire Pharma’s Q2 2024 earnings at ($0.29) EPS, Q3 2024 earnings at ($0.29) […]
Diabetic Retinopathy Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated) marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Ocuphire Pharma (NASDAQ:OCUP) Raised to "Strong-Buy" at Canaccord Genuity Group etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Ocuphire Pharma (NASDAQ:OCUP) Price Target Lowered to $18.00 at Canaccord Genuity Group tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.